Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcabene Multiple-Dose PK/PD Study in Healthy Volunteers
NCT02587364Phase 1Completed
- Sponsor
- NeuroBo Pharmaceuticals
- Start
- Apr 1999
- Primary completion
- Sep 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of gemcabene in hypercholesterolemia (6 arms), sponsored by NeuroBo Pharmaceuticals. Primary endpoint: Pharmacokinetics at 29 days. Started Apr 1999; status: completed.
02
Drugs
gemcabene
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02587364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587364.